Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
8
89%

Phase Distribution

0

Early Stage

8

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
8(100.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

12.5%

1 of 8 finished

Non-Completion Rate

87.5%

7 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(1)
Terminated(7)
Other(1)

Detailed Status

Withdrawn7
unknown1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 28 (100.0%)

Trials by Status

unknown111%
completed111%
withdrawn778%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
PROCEDURE
Total Trials
9